Myriad Systems’ Partners Remain Ahead of the Curve on Good Faith Estimates and the No Surprises Act
Providers and Patients Benefit by Pairing AI-Powered Tools with Human Expertise to Increase Payment Completion at Time of TreatmentWHITE PLAINS,...
Providers and Patients Benefit by Pairing AI-Powered Tools with Human Expertise to Increase Payment Completion at Time of TreatmentWHITE PLAINS,...
First European launch of EKTERLY expected in Germany Q4 2025 EKTERLY now approved in the US, EU, UK and Switzerland...
TIME honors Butterfly’s role in advancing accessible diagnostic imagingBURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (“Butterfly”, “the Company”) (NYSE:...
NEW YORK, Sept. 19, 2025 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the global robot...
Professional and Collegiate Teams Trust MX3's Hydration Testing Technology AUSTIN, Texas, Sept. 19, 2025 /PRNewswire/ -- MX3 Diagnostics, a leader...
BIRMINGHAM, Ala., Sept. 19, 2025 /PRNewswire/ -- Acclinate, the health equity company pioneering community-powered engagement and inclusive clinical trial enrollment,...
Elevating Performance and Efficiency for Clinical and Public Health Labs WILMINGTON, Del., Sept. 19, 2025 /PRNewswire/ -- LabWare, Inc., the...
PARAMUS, N.J., Sept. 19, 2025 /PRNewswire/ -- NS Pharma, Inc. announced today that the U.S. Food & Drug Administration (FDA)...
Annual event recognizes top digital health solutions and connects international thought leaders OLATHE, Kan., Sept. 19, 2025 /PRNewswire/ -- Garmin...
WILMINGTON, Del., Sept. 19, 2025 /PRNewswire/ -- Brand Engagement Network, Inc. (Nasdaq: BNAI) ("BEN"), an innovator in human-like AI Agents...
MESA, ARIZONA / ACCESS Newswire / September 19, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE), a pioneer in AI-powered...
Acquisition of leading cannabis company marks major milestone in InterCure’s commercial expansion strategy, bringing access to premium American brands and...
GAITHERSBURG, Md., Sept. 19, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has secured new purchase...
, Taiwan, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Advanced Biomed Inc. (Nasdaq: ADVB) (the “Company”, “Advanced Biomed”), a biotechnology company...
Pending the European Commission’s final decision, nipocalimab could be the first FcRn blocker approved in both adult and adolescent gMG...
Vancouver, Canada, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a...
Lunsumio provides high and long-lasting response rates, with approximately two-thirds of patients with a complete response in remission after four...
Ra’anana, Israel, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a biotechnology company focusing...
EGOLZWIL, Switzerland, Sept. 19, 2025 (GLOBE NEWSWIRE) -- NTA Implant, a leading brand of the Switzerland-based Pilatus Swiss Dental GmbH,...
OVATION 3 pivotal Phase 3 trial is currently advancing IMNN-001, with several patients being treated LAWRENCEVILLE, N.J., Sept. 19, 2025...